FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to compounds of formula I
or its pharmaceutically acceptable salts wherein R1-3, R5-7, a, X, Y, Y', Y" and Z have the values specified in cl. 1 of the patent claim which are muscarinic receptor antagonists. The invention also refers to pharmaceutical compounds, methods for preparing and methods for using such compounds.
EFFECT: preparing the compounds applicable as muscarinic receptor antagonists.
25 cl, 18 ex
| Title | Year | Author | Number |
|---|---|---|---|
| QUATERNARY AMMONIUM DIPHENYLMETHYL COMPOUNDS USED AS MUSCARINIC RECEPTOR ANTAGONISTS | 2008 |
|
RU2452728C2 |
| BIPHENYL DERIVATIVES | 2004 |
|
RU2330841C2 |
| APELIN RECEPTOR AGONISTS (APJ) AND USE THEREOF | 2015 |
|
RU2705800C2 |
| INHIBITORS OF NONPRILYZINE | 2011 |
|
RU2622288C2 |
| BIPHENYL COMPOUNDS USEFUL AS MUSCARINIC RECEPTOR ANTAGONISTS | 2005 |
|
RU2366656C2 |
| PIPERIDINYL COMPOUNDS FOR SELECTIVE INTEGRINE BINDING | 2003 |
|
RU2333210C2 |
| INDAZOLE-CARBOXAMIDE COMPOUNDS | 2005 |
|
RU2404179C2 |
| DERIVATIVES 1-(ALKYLAMINEALKYL-PYRROLIDINE/PIPERIDINILE)-2,2-DYPHENILACETAMID AS ANTAGONISTS OF MUSCARINE RECEPTORS | 2004 |
|
RU2337095C2 |
| BENZOXAZINYL-AMIDOCYCLOPENTYL-HETEROCYCLIC MODULATORS OF CHEMOKINE RECEPTORS | 2004 |
|
RU2301802C2 |
| M1 MUSCARINE RECEPTOR AGONISTS FOR ANALGETIC THERAPY | 2004 |
|
RU2358735C2 |
